XML 14 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 157,858 $ 83,679
Accounts receivable, net 2,570 4,061
Inventory 3,517 0
Prepaid expenses and other current assets 3,991 2,159
Total current assets 167,936 89,899
Property, plant and equipment, net 5,576 4,480
Operating lease right-of-use assets, net 1,591 1,704
Indemnification asset, related party 6,712 6,707
Contract acquisition costs, net 7,798 7,922
Intangible asset, net 3,376 3,430
Goodwill 3,903 3,903
Other assets 224 287
Total assets 197,116 118,332
Current liabilities:    
Accounts payable 2,490 1,396
Accrued expenses and other current liabilities 14,068 13,400
Revenue interest financing payable, current 4,153 2,615
Operating and finance lease liabilities, current 1,214 1,139
Total current liabilities 21,925 18,550
Litigation finance payable 6,710 6,707
Revenue interest financing payable, noncurrent 80,205 43,418
Operating and finance lease liabilities, noncurrent 2,016 2,364
Total liabilities 110,856 71,039
Commitments and contingencies (Note 13)
Stockholders' equity:    
Preferred stock - 10,000,000 shares authorized, none outstanding 0 0
Common stock - $0.001 par value, 100,000,000 shares authorized as of March 31, 2024 and December 31, 2023 76,287,415 and 68,629,575 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively 76 69
Additional paid-in capital 556,210 476,322
Accumulated deficit (470,026) (429,098)
Total stockholders' equity 86,260 47,293
Total liabilities and stockholders' equity $ 197,116 $ 118,332